Cargando…
Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
BACKGROUND: Memantine is an N‐methyl‐d‐aspartate (NMDA) receptor antagonist that is used to treat moderate to severe Alzheimer's Dementia (AD) and has been speculated to provide clinical benefits in Huntington's disease (HD). OBJECTIVE: To assess the effectiveness of memantine on the traje...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354618/ https://www.ncbi.nlm.nih.gov/pubmed/37476323 http://dx.doi.org/10.1002/mdc3.13763 |